Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SRNE - Sorrento's Scilex repurchases $41.4M notes ahead of going public with SPAC Vickers Vantage


SRNE - Sorrento's Scilex repurchases $41.4M notes ahead of going public with SPAC Vickers Vantage

Sorrento's (NASDAQ:SRNE) subsidiary Scilex Holding on Friday has announced the pre-emptive repurchase of part of its senior secured notes. That allows the pain management company - Scilex - to repurchase $41.4M principal amount of notes on or before Sept. 30, 2022 and the holders of the notes will forgive and discharge $28M of the aggregate amount of notes. It comes ahead of the closing of company's merger transaction. In Mar. 2022, Scilex signed a business combination deal with SPAC Vickers Vantage (NASDAQ:VCKA) to go public at a pro forma equity valuation of ~$1.6B. The combined company is to be listed on Nasdaq under the ticker symbol “SCLX” after the closing of the transaction, expected in Q3 2022. "As we prepare to complete our previously announced merger with Vickers Vantage Corp. I and begin our registration and pre-commercialization plans of our recently successfully completed SP-102 (SEMDEXA) Phase 3 clinical trial program, this

For further details see:

Sorrento's Scilex repurchases $41.4M notes ahead of going public with SPAC Vickers Vantage
Stock Information

Company Name: Sorrento Therapeutics Inc.
Stock Symbol: SRNE
Market: NASDAQ
Website: sorrentotherapeutics.com

Menu

SRNE SRNE Quote SRNE Short SRNE News SRNE Articles SRNE Message Board
Get SRNE Alerts

News, Short Squeeze, Breakout and More Instantly...